Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma
- PMID: 14974863
- DOI: 10.2310/7070.2003.11429
Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma
Abstract
Objective: The follicular variant of papillary thyroid carcinoma (FV-PTC) may be difficult to differentiate from other thyroid neoplasms with follicular architecture such as follicular adenoma, follicular carcinoma, and dominant nodules in nodular goitre. Obvious differences in treatment and expected outcome between these lesions mandate that the distinction between them be made accurately. To decrease the subjectivity of this differential diagnosis, we undertook this study to determine if any difference in cytokeratin profile exists between FV-PTC and other follicular lesions of the thyroid gland.
Design: Immunohistochemical analysis based on a retrospective pathology review.
Setting: Vancouver General Hospital, Vancouver, BC.
Methods: The files of the Vancouver General Hospital anatomic pathology laboratory were searched for cases of typical papillary thyroid carcinoma (PTC), FV-PTC, follicular adenoma, follicular carcinoma, and nodular goitre. The slides and reports were reviewed, and those cases with confirmed diagnosis and adequate tissue were selected for inclusion in the study. Monoclonal antibodies to cytokeratin 19 (CK19), 20 (CK20), and 7 (CK7) were applied to formalin-fixed, paraffin-embedded tissue sections.
Results: All cases of PTC, including FV-PTC, as well as all follicular adenomas, follicular carcinomas, and nodular goitres, stained positively for CK7 and, except for a single follicular carcinoma, were negative for CK20. CK19 decorated almost all PTCs, including FV-PTC, although the staining was sometimes focal. The majority of the cases of follicular adenoma, follicular carcinoma, and nodular goitre were negative or showed focal staining with CK19, although occasional cases showed diffuse positivity.
Conclusions: CK19 strongly stains the majority of PTC, including FV-PTC, in a diffuse manner. However, overlap with the staining seen in other follicular lesions limits its utility in a routine diagnostic setting.
Similar articles
-
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.Am J Clin Pathol. 2001 Nov;116(5):696-702. doi: 10.1309/6D9D-7JCM-X4T5-NNJY. Am J Clin Pathol. 2001. PMID: 11710686
-
Immunohistochemical diagnosis of papillary thyroid carcinoma.Mod Pathol. 2001 Apr;14(4):338-42. doi: 10.1038/modpathol.3880312. Mod Pathol. 2001. PMID: 11301350
-
[Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].Zhonghua Bing Li Xue Za Zhi. 2008 Jan;37(1):35-9. Zhonghua Bing Li Xue Za Zhi. 2008. PMID: 18509983 Chinese.
-
beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas.Endocr Pathol. 2004 Winter;15(4):329-37. doi: 10.1385/ep:15:4:329. Endocr Pathol. 2004. PMID: 15681857 Review.
-
Controversies in thyroid pathology: the diagnosis of follicular neoplasms.Endocr Pathol. 2008 Fall;19(3):156-65. doi: 10.1007/s12022-008-9031-5. Endocr Pathol. 2008. PMID: 18548351 Review.
Cited by
-
CK19 IS A USEFUL MARKER IN DISTINGUISHING FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA FROM BENIGN THYROID LESIONS WITH FOLLICULAR GROWTH PATTERN.Acta Endocrinol (Buchar). 2016 Oct-Dec;12(4):387-391. doi: 10.4183/aeb.2016.387. Acta Endocrinol (Buchar). 2016. PMID: 31149120 Free PMC article.
-
Washout CYFRA 21-1: A tool to improve diagnostic accuracy of fine needle aspiration in the diagnosis of metastatic lymph nodes in papillary thyroid cancer.Heliyon. 2024 May 21;10(11):e31682. doi: 10.1016/j.heliyon.2024.e31682. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38828358 Free PMC article.
-
Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas.J Korean Med Sci. 2005 Oct;20(5):853-9. doi: 10.3346/jkms.2005.20.5.853. J Korean Med Sci. 2005. PMID: 16224162 Free PMC article.
-
Diagnostic accuracy of CK-19, Galectin-3 and HBME-1 on papillary thyroid carcinoma: a meta-analysis.Int J Clin Exp Pathol. 2017 Aug 1;10(8):8130-8140. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966665 Free PMC article.
-
Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis.Endocr Pathol. 2006 Fall;17(3):225-34. doi: 10.1385/ep:17:3:225. Endocr Pathol. 2006. PMID: 17308359
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials